Genetic polymorphisms in AURKA and BRCA1 are associated with breast cancer susceptibility in a Chinese Han population

Journal of Pathology

Volumn 225, Issue 4, 2011, Pages 535-543

  Ruan, Yuan ^a   Song, Ai Ping ^a   Wang, Hui ^a   Xie, Yun Tao ^b   Han, Ji Yuan ^a   Sajdik, Constantin ^c   Tian, Xin Xia ^a   Fang, Wei Gang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^c UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

AURKA; Aurora A; BRCA1; breast cancer; risk; SNP

Indexed keywords

AURORA A KINASE; BRCA1 PROTEIN;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; CONTROLLED STUDY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; UBIQUITIN-PROTEIN LIGASES;

EID: 81355147768     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2902     Document Type: Article

References (32)

1. Wooster R, Weber BL,. Breast and ovarian cancer. N Engl J Med 2003; 348: 2339-2347.
2. Schork NJ, Murray SS, Frazer KA, et al., Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev 2009; 19: 212-219.
3. Gabriel SB, Schaffner SF, Nguyen H, et al., The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-2229.
4. Stram DO, Haiman CA, Hirschhorn JN, et al., Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the multi-ethnic cohort study. Hum Hered 2003; 55: 27-36.
5. Johnson GC, Esposito L, Barratt BJ, et al., Haplotype tagging for the identification of common disease genes. Nat Genet 2001; 29: 233-237.
6. Daly MJ, Rioux JD, Schaffner SF, et al., High-resolution haplotype structure in the human genome. Nat Genet 2001; 29: 229-232.
7. Hinds DA, Stuve LL, Nilsen GB, et al., Whole-genome patterns of common DNA variation in three human populations. Science 2005; 307: 1072-1079.
8. Cox DG, Kraft P, Hankinson SE, et al., Haplotype analysis of common variants in the BRCA1 gene and risk of sporadic breast cancer. Breast Cancer Res 2005; 7: R171-175.
9. Baynes C, Healey CS, Pooley KA, et al., Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk. Breast Cancer Res 2007; 9: R27.
10. Vader G, Lens SM,. The Aurora kinase family in cell division and cancer. Biochim Biophys Acta 2008; 1786: 60-72.
11. Zhou H, Kuang J, Zhong L, et al., Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 1998; 20: 189-193.
12. 2-M transition. J Biol Chem 2004; 279: 19643-19648.
13. Sankaran S, Crone DE, Palazzo RE, et al., Aurora-A kinase regulates breast cancer associated gene 1 inhibition of centrosome-dependent microtubule nucleation. Cancer Res 2007; 67: 11186-11194.
14. Anand S, Penrhyn-Lowe S, Venkitaraman AR,. AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell 2003; 3: 51-62.
15. -/- cells. EMBO J 2002; 21: 483-492.
16. Lo YL, Yu JC, Chen ST, et al., Breast cancer risk associated with genotypic polymorphism of the mitosis-regulating gene Aurora-A/STK15/BTAK. Int J Cancer 2005; 115: 276-283.
17. Yamada Y, Izawa H, Ichihara S, et al., Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med 2002; 347: 1916-1923.
18. Yamada Y, Metoki N, Yoshida H, et al., Genetic factors for ischemic and hemorrhagic stroke in Japanese individuals. Stroke 2008; 39: 2211-2218.
19. Benjamini Y, Hochberg Y,. Controlling the false discovery rate a practical and powerful approach to multiple testing. J Roy Statist Soc Ser B 1995; 57: 289-300.
20. Sun T, Miao X, Wang J, et al., Functional Phe31Ile polymorphism in Aurora A and risk of breast carcinoma. Carcinogenesis 2004; 25: 2225-2230.
21. Dai Q, Cai QY, Shu XO, et al., Synergistic effects of STK15 gene polymorphisms and endogenous estrogen exposure in the risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 2065-2070.
22. Fletcher O, Johnson N, Palles C, et al., Inconsistent association between the STK15 F31I genetic polymorphism and breast cancer risk. J Natl Cancer Inst 2006; 98: 1014-1018.
23. Ewart-Toland A, Dai Q, Gao YT, et al., Aurora-A STK15 T91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types. Carcinogenesis 2005; 26: 1368-1373.
24. Ewart-Toland A, Briassouli P, de Koning JP, et al., Identification of Stk6/STK15 as a candidate low penetrance tumor-susceptibility gene in mouse and human. Nat Genet 2003; 34: 403-412.
25. Eccles D, Tapper W,. The influence of common polymorphisms on breast cancer. Cancer Treat Res 2010; 155: 15-32.
26. Bonnen PE, Wang PJ, Kimmel M, et al., Haplotype and linkage disequilibrium architecture for human cancer-associated genes. Genome Res 2002; 12: 1846-1853.
27. Freedman ML, Penney KL, Stram DO, et al., A haplotype-based case-control study of BRCA1 and sporadic breast cancer risk. Cancer Res 2005; 65: 7516-7522.
28. Haitian Z, Yunfei L, Jian Z, et al., Mutation screening of the BRCA1 gene in sporadic breast cancer in southern Chinese populations. Breast 2008; 17: 563-567.
29. Song CG, Hu Z, Wu J, et al., The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer. J Cancer Res Clin Oncol 2006; 132: 617-626.
30. Qiu WX, Shen DH, Zhang YX,. [BRCA gene mutation in breast and ovary tumors]. Zhonghua Bing Li Xue Za Zhi 2003; 32: 59-61.
31. Onay VU, Briollais L, Knight JA, et al., SNP-SNP interactions in breast cancer susceptibility. BMC Cancer 2006; 6: 114.
32. Ding SL, Yu JC, Chen ST, et al., Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility. Carcinogenesis 2009; 30: 43-49.